CT DOL H-1B

Tract Pharmaceuticals Inc.: H-1B Sponsorship Profile

Tract Pharmaceuticals Inc. in CT is dominated by DOL H-1B labor-condition applications (2 on file) at a $104,941 disclosed median; OSHA and WARN tracks are empty here.

Verify with OSHA → · BLS OEWS →
Subscribe to WARN notice updates (RSS)
Tract Pharmaceuticals Inc. workforce trust profile One rising office-tower pillar encoding federal-records percentiles for the tracks this employer carries. Tract Pharmaceuticals Inc. Federal records · signal DOL H-1B 255075100 52 signal Hiring 2 filings
Higher = stronger signal vs. peers (live corpus percentile 0–100 per axis present on this profile). Source: DOL OFLC.

Tract Pharmaceuticals Inc. (CT): · 2 H-1B LCAs at a $104,941 disclosed median

According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Tract Pharmaceuticals Inc. in CT carries 2 H-1B wage filings on record, a $104,941 median wage across 1 disclosed-wage positions (below the $124,488 national median) and no WARN layoff notices on file. H-1B filing volume ranks #16,368 of 51,370 sponsors in this corpus (about the 52nd percentile). Every figure is a federal filing, not an estimate; see methodology for coverage limits.

  • 2 H-1B LCAs
  • $104,941 median wage

The record at a glance

According to U.S. Department of Labor, OSHA, and state WARN Act filings, Tract Pharmaceuticals Inc. carries 2 H-1B wage filings on record, a $104,941 median wage across 1 disclosed-wage positions (below the $124,488 national median) and no WARN layoff notices on file. In this corpus, H-1B filing volume ranks #16,368 of 51,370 sponsors in this corpus (about the 52nd percentile), and disclosed median wage sits at the 32nd percentile of 272,125 credible H-1B wage rows.

2
H-1B filings
$104,941
median H-1B wage
0
WARN notices

Figures above come from DOL H-1B labor condition applications only, OSHA and WARN tracks are empty on this profile.

F
Federal workforce composite
30/100
3 of 4 federal tracks · Tract Pharmaceuticals Inc.

A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.

Sponsorship scale C-
2 H-1B LCAs
#16,368 of 51,370 sponsors · 52nd percentile by volume (DOL OFLC)
Disclosed pay F
$104,941 median
32nd percentile of 272,125 credible H-1B wage rows
Workplace safety N/A
No OSHA record
No employer-specific OSHA ITA injury log; weight redistributes (industry estimates never pad this dim).
Layoff stability F
0 WARN notices
Cleaner WARN history than 14% of 304,376 tracked employers (state workforce agencies)

Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.

H-1B Filings

2

DOL labor condition applications on file

Median H-1B Salary

$104,941

Across 1 disclosed positions

Where Tract Pharmaceuticals Inc.'s H-1B wage sits nationally

Median disclosed wage vs. all US employers with H-1B filings

$104,941 Top 68% higher than 32% of 272,125 US employers

$0–$20,000: 1 US employers (0%). Below this entry. $20,000–$40,000: 401 US employers (0%). Below this entry. $40,000–$60,000: 7,591 US employers (3%). Below this entry. $60,000–$80,000: 24,066 US employers (9%). Below this entry. $80,000–$100,000: 43,829 US employers (16%). Below this entry. $100,000–$120,000: 49,740 US employers (18%). This entry sits in this band. $120,000–$140,000: 42,626 US employers (16%). Above this entry. $140,000–$160,000: 33,306 US employers (12%). Above this entry. $160,000–$180,000: 22,983 US employers (8%). Above this entry. $180,000–$200,000: 15,711 US employers (6%). Above this entry. $200,000–$220,000: 10,825 US employers (4%). Above this entry. $220,000–$240,000: 6,806 US employers (3%). Above this entry. $240,000–$260,000: 4,579 US employers (2%). Above this entry. $260,000–$280,000: 2,975 US employers (1%). Above this entry. $280,000–$300,000: 1,671 US employers (1%). Above this entry. $300,000–$320,000: 5,015 US employers (2%). Above this entry. Tract Pharmaceuticals Inc. $0 $320,000 every US employer with H-1B filings, bucketed by value

Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026

Government Data Summary

Field Value Source
Employer Name Tract Pharmaceuticals Inc. DOL OFLC
Industry Not reported NAICS / DOL
State CT U.S. Federal Records
H-1B Filings 2 DOL OFLC LCA Disclosure
H-1B Median Salary $104,941 DOL OFLC LCA Disclosure
Tracks not on file employer OSHA injury log, WARN notices Empty by design, not estimated

Tract Pharmaceuticals Inc.'s values above reflect the most recent DOL Labor Condition Applications on file for this employer in CT. In this corpus, H-1B filing volume ranks #16,368 of 51,370 sponsors in this corpus (about the 52nd percentile); disclosed median wage sits at the 32nd percentile of 272,125 credible H-1B wage rows; WARN history is cleaner than 14% of 304,376 employers tracked here.

H-1B Salary Data

Job Title Median
Bioanalytical Scientist (LC-MS) $104,941

What the Data Says About Tract Pharmaceuticals Inc.

Signature stat: WARN history

Even with zero WARN notices, Tract Pharmaceuticals Inc. still sits in the bottom third for layoff cleanliness — other employers have equally quiet records.

Below-median disclosed pay

Disclosed pay runs low: $104,941 median trails 68% of wage rows and sits under the $124,488 national median.

Mid-tier sponsorship volume

Tract Pharmaceuticals Inc. in CT carries 2 H-1B LCAs, of which 1 disclose a usable wage figure and a $104,941 disclosed median, middle-of-the-pack among sponsors tracked here.

OSHA record absent

Tract Pharmaceuticals Inc. has H-1B LCAs on file but no employer OSHA injury log in this corpus; the two disclosures run on unrelated federal systems.

What to check before working with Tract Pharmaceuticals Inc.

For Tract Pharmaceuticals Inc., start with sponsorship pay (2 H-1B LCAs, median $104,941) and only then layer any other federal silence.

  • H-1B median is $104,941 across 1 disclosed-wage positions (of 2 total filings), benchmark any offer against it and the metro prevailing wage. Compare with peers

Tract Pharmaceuticals Inc.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.

Read with this employer

Retrieved and formatted by PlainEmployers.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.

Frequently Asked Questions

Where does Tract Pharmaceuticals Inc.'s H-1B wage sit nationally?

Among 272,125 credible H-1B wage rows in this corpus, Tract Pharmaceuticals Inc.'s disclosed median of $104,941 sits at the 32nd percentile (below the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.

How does Tract Pharmaceuticals Inc.'s H-1B filing volume compare to other sponsors?

Tract Pharmaceuticals Inc. has 2 H-1B filings on record, ranking #16,368 of 51,370 sponsors in this corpus (about the 52nd percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.

Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation

This profile is rendered directly from DOL H-1B disclosure filings, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.